Juventis

Juventis operates in Miami, Florida, providing peptide-based protocols for weight loss management, metabolic optimization, and age-related wellness concerns. The clinic structures treatment plans around individual metabolic profiles and health objectives, with particular emphasis on body composition changes and hormonal balance restoration. Patients seeking alternatives to conventional weight management or those experiencing age-related metabolic decline comprise the primary patient population at this Miami facility.

The clinic's peptide offerings center on two primary therapeutic agents: Tirzepatide for weight management and metabolic regulation, and NAD+ (nicotinamide adenine dinucleotide) supplementation for cellular energy production and anti-aging applications. Tirzepatide, a dual GIP/GLP-1 receptor agonist, is administered as part of structured weight loss protocols that include dosing schedules tailored to individual tolerance and response patterns. NAD+ therapy at Juventis addresses cellular senescence, mitochondrial function decline, and age-related NAD+ depletion through intravenous or subcutaneous administration routes. The clinic positions these peptides within broader treatment frameworks that may incorporate nutritional guidance, metabolic testing, and hormone level assessment to establish baseline function and track therapeutic response.

Juventis structures its anti-aging and hormone support services around the understanding that declining hormone production, cellular energy deficits, and metabolic dysregulation contribute to common aging symptoms including reduced stamina, cognitive changes, body composition shifts, and diminished recovery capacity. The hormone support component addresses imbalances that affect weight regulation, energy levels, and overall vitality, though specific hormone replacement protocols are individualized based on laboratory findings and symptom presentation. The Miami clinic's approach integrates peptide therapy with hormone optimization strategies, recognizing that these systems interact to influence metabolic rate, muscle preservation, and fat distribution patterns.

Patients initiating care at Juventis typically undergo initial consultations that include health history review, current medication assessment, and discussion of treatment goals related to weight management or age-related concerns. Laboratory testing establishes baseline hormone levels, metabolic markers, and other relevant health indicators before peptide protocols begin. Tirzepatide programs involve regular follow-up to monitor weight changes, adjust dosing, and address any side effects, while NAD+ therapy schedules vary based on whether patients pursue ongoing maintenance or intensive initial loading phases. The clinic provides administration training for patients using at-home injectable peptides and schedules in-office visits for intravenous NAD+ infusions when that delivery method is selected.

Located in Miami, Juventis serves patients throughout South Florida seeking peptide-based approaches to metabolic health and aging management. The clinic's focus on these specific peptide applications—Tirzepatide for weight regulation and NAD+ for cellular health—distinguishes its service model from broader functional medicine practices. Patients considering care at Juventis should prepare for a protocol-driven approach that requires commitment to follow-up schedules, potential lifestyle modifications alongside peptide therapy, and realistic expectations about the timeline for observable changes in weight, energy levels, or other targeted health markers.